Amanote Research

Amanote Research

    RegisterSign In

Recommended Drug Therapies for Inflammatory Bowel Disease

Prescriber - United Kingdom
doi 10.1002/psb.1701
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

September 1, 2018

Authors
Christopher WhiteAmit ThakorRishi Goel
Publisher

Wiley


Related search

Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Gastroenterology
HepatologyGastroenterology
2017English

Review Article: Novel Oral-Targeted Therapies in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Physiological Basis for Novel Drug Therapies Used to Treat the Inflammatory Bowel Diseases I. Immunology and Therapeutic Potential of Antiadhesion Molecule Therapy in Inflammatory Bowel Disease

American Journal of Physiology - Gastrointestinal and Liver Physiology
HepatologyPhysiologyGastroenterology
2005English

Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects

Frontiers in Immunology
AllergyImmunology
2017English

TNF Blocking Therapies and Immunomonitoring in Patients With Inflammatory Bowel Disease

Mediators of Inflammation
ImmunologyCell Biology
2014English

Rifaximin for Inflammatory Bowel Disease

Digestive Diseases and Sciences
PhysiologyGastroenterology
2010English

Inflammatory Bowel Disease

Annual Review of Immunology
AllergyImmunology
2010English

Inflammatory Bowel Disease

American Journal of Gastroenterology
HepatologyGastroenterology
2007English

"Inflammatory" Bowel Disease.

BMJ
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy